# Delivery Order #SPE2D326F236Q

Pfizer Delivery Order for Injectable Lidocaine

**Buyer:** Defense Logistics Agency

**Award Amount:** $25.00
**Ceiling:** $25.00

**Awarded:** July 02, 2026
**Period of Performance:** Jul 02, 2026 - Jul 06, 2026

**Identifier:** SPE2D326F236Q
**NAICS:** 325412

This delivery order under a Defense Logistics Agency indefinite-delivery contract calls for Pfizer Inc. to supply 2% lidocaine hydrochloride in 20-milliliter vials. Pfizer is a pharmaceutical manufacturer, and the medication is used as a local anesthetic. The order supports the availability of essential medicines for federal and military healthcare needs; the record identifies performance in New York. It is placed under the parent contract for pharmaceutical manufacturing and distribution, which is scheduled to run over a long-term period. The award record does not state whether this individual order was competed or issued on a sole-source basis, nor does it provide subcontractor, acquisition-program, or solicitation details. The order has a short performance window, beginning and ending in early July 2026.

### Description

4572289122!LIDOCAINE HCL 2% VIAL 20ML

[View original record](https://www.usaspending.gov/award/CONT_AWD_SPE2D326F236Q_9700_SPE2D020D0014_9700)
